ARCHIVES

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Cancergrams Cost $840 Year For All

December 2, 1977

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

Opioid Pain Reliever Approved With Risk Reduction Plan

July 31, 2009

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980

AACR Grant Programs. NIH RFA Available.

June 29, 2001

(8-page issue)

November 2, 2002